Aralast
List of products in the National Drug Code with proprietary name aralast. This medication is used to treat lung problems (emphysema) caused by a certain inherited disease (alpha-1-proteinase inhibitor deficiency). In people with this condition, lung damage is caused by elastase, a natural substance that the body needs to kill bacteria in the lungs. Normally, a protein (alpha-1-proteinase inhibitor) stops elastase from working when it is no longer needed. However, in people who do not make enough of this protein, elastase does not stop working and damages the lungs. This medication replaces the missing alpha-1-proteinase inhibitor and helps to prevent further lung damage.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
0944-2814 | Aralast NP | Alpha-1-proteinase Inhibitor (human) | Kit | Takeda Pharmaceuticals America, Inc. | Plasma Derivative | |
0944-2815 | Aralast NP | Alpha-1-proteinase Inhibitor (human) | Kit | Takeda Pharmaceuticals America, Inc. | Plasma Derivative |